featured
Sexual Dysfunction With 5-Alpha-Reductase Inhibitor Therapy for Androgenetic Alopecia
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of the American Academy of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Sexual dysfunction with 5-alpha-reductase inhibitor therapy for androgenetic alopecia: a global propensity score matched retrospective cohort study
J Am Acad Dermatol 2024 Mar 27;[EPub Ahead of Print], KC Lauck, A Limmer, P Harris, D KivelevitchFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.